George Sellers
Stock Analyst at Stephens & Co.
(1.07)
# 3,797
Out of 5,182 analysts
45
Total ratings
28.57%
Success rate
-6.94%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Overweight | $85 → $90 | $65.23 | +37.97% | 8 | Feb 25, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $115 → $145 | $120.11 | +20.72% | 5 | Jan 2, 2026 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $135.65 | +113.79% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $35.62 | +62.85% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $101.00 | +76.24% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $15.76 | +52.28% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $23.81 | +202.39% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.70 | +35.14% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $1.93 | +1,195.34% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $25.92 | +119.91% | 6 | Aug 14, 2023 |
Establishment Labs Holdings
Feb 25, 2026
Maintains: Overweight
Price Target: $85 → $90
Current: $65.23
Upside: +37.97%
Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115 → $145
Current: $120.11
Upside: +20.72%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $135.65
Upside: +113.79%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $35.62
Upside: +62.85%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $101.00
Upside: +76.24%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $15.76
Upside: +52.28%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $23.81
Upside: +202.39%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.70
Upside: +35.14%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $1.93
Upside: +1,195.34%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $25.92
Upside: +119.91%